Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Nov 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how people with Alzheimer's disease, Parkinson's disease, and healthy older adults engage with music in their daily lives. Researchers want to understand the different ways these groups experience music, including how their memory and emotional responses to music might vary. The study involves interviews and tests conducted by a neuropsychologist to gather information about each participant's musical experiences and cognitive abilities.
To join the study, participants need to be at least 60 years old, speak French, and live at home with a family member. They should have a diagnosis of Alzheimer's or Parkinson's disease, but their mental abilities must be adequate, as indicated by a specific test score. Participants can expect to take part in a 2-hour interview that includes questions about their background and cognitive tests, which may involve input from a family member. This study is important because it could help researchers learn more about the connection between music and brain health in these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- General inclusion criteria:
- • 60 years and older
- • French-speaking and volunteering for the study
- • Living at home with a relative
- Alzheimer's disease inclusion criteria:
- • Biological diagnosis of probable Alzheimer's disease according to NINCDS-ADRDA criteria (McKhann et al., 1984)
- • MMSE greater than or equal to 20
- Inclusion criteria Parkinson's disease :
- • Diagnosis of Idiopathic Parkinson's disease
- • MMSE greater than or equal to 20
- Exclusion Criteria:
- • No known neurological pathologies (epilepsy and other non-degenerative CNS diseases) or psychiatric disorders (chronic psychosis and psychotic episodes)
- • Autistic disorders
- • History of stroke or head trauma
- • Unstable medical condition (cancer)
- • Subject unable to read and/or write
- • Hearing impairment without hearing aids
- • Refusal of consent after information
- • Persons unable to give consent, research carried out in emergency situations, etc.)
- • Non-affiliation with a social security scheme
- • Person deprived of liberty (by judicial or administrative decision, or forced hospitalization)
- • Person under legal protection (guardianship, curatorship, legal protection)
- • Person participating in another research project with an exclusion period still in progress
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, Hérault, France
Montpellier, Hérault, France
Montpellier, Hérault, France
Montpellier, , France
Montpellier, , France
Montpellier, , France
Patients applied
Trial Officials
KARIM BENNYS, MD
Principal Investigator
University Hospital, Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported